Return
Phytochemical Engineered Quantum Dots as Potential Therapy to Counter Alpha Synuclein aggregation in Parkinson’s disease
P
A
M
A
J
DOI:10.1016/j.neuint.2026.106194.png)
Abstract
En 中文
• Phytochemical-CQDs inhibit α-synuclein aggregation in Parkinson's models. • Green-synthesized CQDs enhance BBB crossing and nutraceutical bioavailability. • CQDs with curcumin/resveratrol reduce PD oxidative stress, neurotoxicity. • Nano-phytomedicine provides multifunctional therapy for brain dysfunction.
Journal
IF:
4
Papers:
5.3K
Citations:
1.0W
